@article {45718,
	title = {Cell culture processes for biopharmaceutical manufacturing},
	journal = {Current Science},
	volume = {112},
	year = {2017},
	month = {APR },
	pages = {1478-1488},
	type = {Article},
	abstract = {<p>Recombinant proteins manufactured using animal cell culture processes comprise a significant fraction of biopharmaceuticals. With the expiry of patents on this class of therapeutics, there is also a significant interest in manufacture of biosimilar versions of such therapeutics. This article provides a birds-eye view of upstream process development for animal cell culture processes, with a focus on advances pertinent to the development of processes for biosimilars.</p>},
	keywords = {Biopharmaceutical, Cell line development, CHO, glycosylation, monoclonal antibody},
	issn = {0011-3891},
	doi = {10.18520/cs/v112/i07/1478-1488},
	author = {Gadgil, Mugdha}
}
